The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis / Andreas Maetzel, Murray Krahn, Gary Naglie
Contributors: Maetzel, Andreas; Krahn, Murray; Naglie, Gary; Canadian Coordinating Office for Health Technology Assessment
Series: Technology report ( Canadian Coordinating Office for Health Technology Assessment) ; issue 23
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Language: eng
Number of pages: 39
Subjects: Arthritis -- Drug Therapy; Rheumatic Diseases -- Drug Therapy
Notes: 27